Sixty-day dispensing medication shortages yet to materialise The CEO of Australia’s largest pharmaceutical distributor says there has been ‘very little change in demand’ during the initial weeks of the new policy.
Sixty-day dispensing: What GPs need to know After a long and hard-fought push, the landmark changes will finally be in place from September. Here’s what to expect when the reform goes live.
Migraine and sarcoma medications added to PBS Subsidised treatment options for people with metastatic hormone-sensitive prostate cancer have also been expanded.
GPs key for equitable access to glucose monitors: RACGP An ongoing NDSS review has sparked renewed calls to allow GPs to certify patients with diabetes for access to subsidised continuous glucose monitors.
Changes made to COVID Vaccine Claims Scheme The Department of Health and Aged Care has removed and added certain conditions that can be claimed in relation to COVID vaccine adverse reactions.
New year brings cheaper medicines The maximum cost of subsidised prescriptions has been cut for the first time since the PBS was introduced 75 years ago.
Reflux treatment among medicines added to PBS Medication for a host of conditions will be newly subsidised from October, potentially generating $130 million in out-of-pocket savings.
‘Nonsensical’ to stop GPs approving access to glucose monitors The decision to block GPs from certifying patient access to the devices ‘needs to be reviewed and rectified,’ the RACGP president says.
COVID antiviral order doubled ahead of PBS listing Paxlovid will be available on the Pharmaceutical Benefits Scheme from May, with ‘really positive responses’ reported so far.
Thousands expected to benefit from new PBS listings Medications for asthma, HIV, and Crohn’s disease have been added, while some heart, cholesterol and blood pressure drugs are now cheaper.